David M. Polen
Polen Capital Management
Polen Capital Management Portfolio 13F
Polen Capital Management Holdings Activity
- Portfolio value:
- $7.28B≈ (+$817M≈)
- Previous value:
- $6.47B≈
- # of changes:
- 27
- New positions:
- 1
- Reported for:
- 31 Mar 2016 (Q1)
- Latest filing date:
- 16 May 2016
Polen Capital Management has disclosed a total of 27 changes to the portfolio in the (2016 Q1) SEC report(s): increased the number of shares of 24, bought 1 totally new and decreased the number of shares of 2 position(s).
What stocks did Polen Capital Management buy in 2016 Q1?
During 2016 Q1 Polen Capital Management has bought 25 securities out of which top 5 purchases (by % change to portfolio) were (V) Visa Inc, CL-A (added shares +12.41%), (NKE) Nike Inc (added shares +11.83%), (GOOG) Alphabet Inc, CL-C (added shares +18.47%), (SBUX) Starbucks Corp (added shares +12.14%) and (TJX) The TJX Companies Inc (added shares +11.67%).
In the 2016 Q1 report(s) the following changes have been made to the top investments: (V) Visa Inc, CL-A (added shares +12.41%), (NKE) Nike Inc (added shares +11.83%), (GOOG) Alphabet Inc, CL-C (added shares +18.47%), (SBUX) Starbucks Corp (added shares +12.14%) and (TJX) The TJX Companies Inc (added shares +11.67%).
27 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Align Technology Inc
|
new
|
$72.69
|
+138.93%($173.68)
|
1.50%
|
2016 Q1
|
≈ 0.25 years
|
||||
|
|
Celgene Corp
|
+62.67%
|
$100.09
|
|
4.07%
|
2014 Q4
|
≈ 1.50 years
|
||||
|
|
Novo Nordisk A/S
|
+18.97%
|
$54.19
|
-17.14%($44.90)
|
0.01%
|
2015 Q4
|
≈ 0.50 years
|
||||
|
|
CHECK POINT SOFTWARE TECH
|
+18.96%
|
$87.47
|
+42.95%($125.04)
|
0.01%
|
2015 Q3
|
≈ 0.75 years
|
||||
|
|
Alibaba Group Holding Ltd
|
+18.72%
|
$79.08
|
+62.38%($128.41)
|
0.01%
|
2015 Q4
|
≈ 0.50 years
|
||||
|
|
Alphabet Inc, CL-C
|
+18.47%
|
$37.25
|
+862.99%($358.69)
|
6.55%
|
2014 Q2
|
≈ 2.00 years
|
||||
|
|
Baidu Inc
|
+18.34%
|
$190.80
|
-41.64%($111.35)
|
0.01%
|
2015 Q4
|
≈ 0.50 years
|
||||
|
|
Nestle SA ADR
|
+15.36%
|
$75.03
|
+34.43%($100.86)
|
4.38%
|
2014 Q2
|
≈ 2.00 years
|
||||
|
|
Fastenal Company
|
+14.57%
|
$12.25
|
+309.67%($50.18)
|
4.30%
|
2013 Q2 or earlier
|
≈ 3.00+ years
|
||||
|
|
Regeneron Pharmaceuticals Inc
|
+12.85%
|
$360.44
|
+113.91%($771.00)
|
3.49%
|
2013 Q2 or earlier
|
≈ 3.00+ years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.